Deep learning and inflammatory markers predict early response to immunotherapy in unresectable NSCLC: A multicenter study. Biomol Biomed [Internet]. 2025 Jun. 10 [cited 2025 Sep. 29];25(10):2252–2268. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/12324